Redeye: Bong - Stable margins despite dwindling volumes
Redeyes was again surprised by the magnitude of the volume decline in the third quarter. Sales decreased by 10% Y/Y, and adjusted for currency effects, by 19%. Bong now expects sluggish demand into H1’24. On a positive note, EBITDA margins were still on par with H1’23 at around 6%, despite significantly lower volumes. We are adjusting our near-term top-line forecasts leading to a somewhat lower valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/